Aeterna Zentaris Inc (NASDAQ:AEZS)

CAPS Rating: 2 out of 5

A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.

AEZS News and Commentary

Caps

How do you think AEZS will perform against the market?

Add Stock to CAPS Watchlist

All Players

318 Outperform
19 Underperform
 

All-Star Players

26 Outperform
8 Underperform
 

Wall Street

10 Outperform
0 Underperform
 

Top AEZS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

vaderblue (< 20)
Submitted November 15, 2011

I am convienced AEZS is on the right track but only time will tell. I am betting on AEZS to succeed. After all the shares are cheap and owning some shares may be a good thing in the long run.

YoungScientist63 (96.72)
Submitted January 18, 2007

Uhhhh............ it will just do bad. :) --A Scientist

AEZS VS S&P 500 (SPY)

Fools bullish on AEZS are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about AEZS.

Recs

0
Member Avatar Fiskhus (63.40) Submitted: 8/26/2017 4:34:34 PM : Outperform Start Price: $1.91 AEZS Score: +0.25

TA1 w/earnings & zzzz6BuyComboMinimums

Recs

0
Member Avatar Jibo999 (< 20) Submitted: 1/20/2014 3:02:49 PM : Outperform Start Price: $1.35 AEZS Score: +10.27

Super rich pipeline

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/15/2013 2:53:46 PM : Outperform Start Price: $1.66 AEZS Score: -23.92

mako

Leaderboard

Find the members with the highest scoring picks in AEZS.

Score Leader

zzlangerhans

zzlangerhans (99.83) Score: +618.34

The Score Leader is the player with the highest score across all their picks in AEZS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Simonkommerz < 20 1/29/2015 Outperform 1Y $0.53 +309.42% +38.70% +270.72 0 Comment
portefeuille6 99.74 5/1/2015 Outperform 5Y $0.56 +288.87% +32.63% +256.24 0 Comment
longtermgrowth09 < 20 8/3/2010 Underperform 5Y $6.72 -67.71% +147.08% +214.79 0 Comment
Nivaos < 20 4/15/2010 Underperform 1Y $9.90 -78.08% +129.70% +207.79 0 Comment
Okcfirefighter < 20 12/17/2010 Underperform 3Y $10.38 -79.10% +123.50% +202.59 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. YoungScientist63 96.72 1/19/2007 Underperform 1Y $26.28 -91.74% +106.95% +198.69 4 Comments
Azurepoet 96.03 5/14/2007 Underperform NS $21.84 -90.06% +94.77% +184.83 0 Comment
jazper292 22.36 6/6/2007 Underperform 1Y $21.18 -89.75% +93.24% +183.00 0 Comment
FoolPep 31.03 6/8/2017 Outperform 3M $1.14 +90.34% +14.01% +76.33 0 Comment
TruffelPig < 20 2/13/2017 Underperform 5Y $3.27 -33.61% +19.75% +53.36 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackMaximGroup 62.24 11/6/2014 Outperform NS $0.63 +244.70% +37.32% +207.38 0 Comment
TrackRothCapital 72.78 9/20/2012 Outperform NS $4.44 -51.13% +90.32% -141.45 0 Comment
TrackUltraLong < 20 11/3/2011 Outperform NS $10.08 -78.47% +121.86% -200.33 1 Comment
TrackNeedham 91.56 5/31/2011 Outperform NS $15.00 -85.53% +106.22% -191.75 0 Comment
trackmlvcapital < 20 11/29/2010 Outperform NS $8.04 -73.01% +134.53% -207.54 0 Comment
TrackRBCCapMkts 88.60 8/15/2007 Outperform NS $14.88 -85.42% +105.52% -190.94 0 Comment
TrackOppenheimer 60.66 5/15/2007 Outperform NS $21.48 -89.90% +94.97% -184.87 0 Comment
TrackRodmanRen < 20 5/9/2007 Outperform NS $22.08 -90.17% +94.82% -184.99 0 Comment
TrackJanney 81.88 12/28/2006 Outperform NS $14.90 -85.44% +107.14% -192.58 0 Comment
TrackCanaccord < 20 9/18/2006 Outperform NS $18.33 -88.16% +123.86% -212.02 0 Comment

Featured Broker Partners